Director of Odonate Therapeutics, Inc. (NASDAQ:ODT), Davis Aaron I., buys 100,000 shares worth $1,746,380
According to Odonate Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 06:18 PM, company Director, Davis Aaron I. disclosed buying 100,000 shares at a cost of $17.46. At the time of this transaction (Dec 30), this trade was worth $1,746,380 in total. As of Dec 30, Davis Aaron I. now owns 5,607,086 shares in total worth about $98,404,359.3.
For the last few recent trades made by Odonate Therapeutics, Inc. (NASDAQ:ODT) Director, Davis Aaron I., we have the following information:
- SEC Form 4 filing: Dec 28: Bought 75,000 shares at the rate of $16.90 per share. Total worth of this trade was $1,267,500. Total number of shares owned as of Dec 28 were 5,282,086
- SEC Form 4 filing: Dec 29: Bought 225,000 shares at the rate of $17.11 per share. Total worth of this trade was $3,849,548. Total number of shares owned as of Dec 29 were 5,507,086
- SEC Form 4 filing: Sep 28: Bought 93,200 shares at the rate of $13.03 per share. Total worth of this trade was $1,214,396. Total number of shares owned as of Sep 28 were 5,085,086
Posted by
George Daniels
on Wednesday December 30 2020, 10:39 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
